Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Rapid Growth Of Layoffs In Pharma, As Industry Despairs Of Its Future
247WallSt
Friday, September 24, 2010 - 11:09am
tags:
Wyeth, Schering Plough, Pfizer, Merck, layoffs, Bristol-Myers Squibb, Abbott Laboratories
Avandia: Lessons Learned & Unanswered Questions
Pharmalot
Friday, September 24, 2010 - 10:11am
tags:
Avandia, GSK, diabetes
AstraZeneca Wins EU Approval for Blood Thinner to Rival World's No. 2 Drug
Bloomberg
Friday, September 24, 2010 - 10:03am
tags:
AstraZeneca, blood thinners, Europe, Plavix, Brilique, Brilinta
Similac Recall and Response - Consumer Outrage
TheStreet.com
Friday, September 24, 2010 - 10:01am
tags:
Abbott Laboratories, recalls, infant formula, Similac
Novartis to Sell U.S. Rights to Enablex
TheStreet.com
Friday, September 24, 2010 - 9:58am
tags:
Novartis, Enablex, Warner Chilcott, overactive bladder
Merck KGaA drops 10 per cent after drug rejection
FT.com
Friday, September 24, 2010 - 9:57am
tags:
Merck KGaA, MS, multiple sclerosis
Gilenya: A Blockbuster in Due Time
Motley Fool
Friday, September 24, 2010 - 9:55am
tags:
Gilenya, MS, multiple sclerosis, Novartis
Drugmaker Bristol-Myers Squibb is streamlining, will cut 840 jobs worldwide in next 6 months
Yahoo/AP
Thursday, September 23, 2010 - 5:35pm
tags:
layoffs, reorganization, Bristol-Myers Squibb
Regulators pull plug on Glaxo diabetes drug: Europe orders marketing halt, U.S. orders restrictions
Marketwatch
Thursday, September 23, 2010 - 2:57pm
tags:
GSK, Europe, FDA, diabetes, Avandia, Avaglim, Avandamet
Reata-Abbott deal may be worth $800M-plus
Bizjournals.com
Thursday, September 23, 2010 - 2:55pm
tags:
Abbott Laboratories, Reata, drug development
Big Pharma's Challenge: Figuring out China
CNN/Fortune
Thursday, September 23, 2010 - 2:52pm
tags:
China, Big Pharma, Pfizer, GSK, Sanofi
FDA Restricts Glaxo Diabetes Drug Avandia
TheStreet.com
Thursday, September 23, 2010 - 2:50pm
tags:
FDA, diabetes, Avandia, GSK
Will There Be Generic User Fees? Ramsey Explains
Pharmalot
Thursday, September 23, 2010 - 9:47am
tags:
generics, FDA, Mylan
AZ/Rigel RA drug hits PhIIb paydirt
Fierce Biotech
Thursday, September 23, 2010 - 9:45am
tags:
Rigel, rheumatoid arthritis, AstraZeneca
Did drugmaker hide birth control patch risks?
MSNBC
Thursday, September 23, 2010 - 9:44am
tags:
JNJ, birth control patch, Ortho Evra
U.S. sees bowel risk in early Glaxo vaccine data
Reuters
Thursday, September 23, 2010 - 9:43am
tags:
GSK, vaccines, Rotarix, rotavirus
Restructuring at Abbott Labs
Yahoo/Zacks.com
Thursday, September 23, 2010 - 9:41am
tags:
Abbott Laboratories, restructuring
Biosimilars: This Decade's Most Disruptive Technology
PharmExec
Thursday, September 23, 2010 - 9:40am
tags:
biosimilars
Third Rock leads $30M round for antibody upstart CytomX
Fierce Biotech
Thursday, September 23, 2010 - 7:55am
tags:
CytomX, venture capital, antibodies
House Passes Bill To Ban Execs For Healthcare Fraud
Pharmalot
Thursday, September 23, 2010 - 7:51am
tags:
healthcare fraud, healthcare reform

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.